1. Home
  2. KEQU vs TVGN Comparison

KEQU vs TVGN Comparison

Compare KEQU & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$34.88

Market Cap

106.3M

Sector

Industrials

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$7.81

Market Cap

21.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
TVGN
Founded
1906
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Blank Checks
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
106.3M
21.3M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
KEQU
TVGN
Price
$34.88
$7.81
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1K
6.5K
Earning Date
03-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.58
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$62.26
N/A
Revenue Growth
7.72
N/A
52 Week Low
$32.00
$0.14
52 Week High
$46.57
$12.03

Technical Indicators

Market Signals
Indicator
KEQU
TVGN
Relative Strength Index (RSI) 42.12 67.37
Support Level $32.99 $6.22
Resistance Level $35.35 $7.90
Average True Range (ATR) 1.21 0.41
MACD -0.11 0.04
Stochastic Oscillator 53.13 88.98

Price Performance

Historical Comparison
KEQU
TVGN

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Its products include steel and wood casework, fume hoods, adaptable modular systems, movable workstations, stand-alone benches, biological safety cabinets, epoxy resin work surfaces, and sinks. The company operates through two reportable segments: Lab Products Group (LPG), which designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, flexible systems, work surfaces, workstations, workbenches, and computer enclosures, and the International segment.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: